Pioneering milk business, The a2 Milk Company (ASX:A2M), performed well during the quarter despite being down 14.3% for the month of December on the back of concerns around the current predicament of its listed peer, Bellamy’s Australia (ASX:BAL) (-45.7% for the month of December). BAL issued a profit warning in early December cutting its earnings forecast by 40-50% and citing lower volumes and margins through its Chinese sales channels. In mid-December, Bellamy’s moved to suspend its ASX listing as it attempted to come to grips with its rapidly changing earnings profile. This had an unsettling impact on the A2M share price although the company subsequently confirmed that it “continues to trade very strongly, in particular, (with) significant year-on-year growth in its infant formula business”. Prior to the market jitters caused by BAL, A2M had released a strong AGM update with sales for the first four months of FY17 up 96%, which we believe provides evidence the company continues to build a substantial premium milk business. (VIEW LINK)
Robert was appointed Head of Investments in 2009 and has been a Portfolio Manager since joining OC Funds Management in 2001. Robert is also an Executive Director of parent company, Copia Investment Partners. Robert is responsible for the...
No areas of expertise